Tue, Jan 27, 2015, 6:15 AM EST - U.S. Markets open in 3 hrs 15 mins

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • steves.1977 steves.1977 Sep 20, 2012 9:32 AM Flag

    Adam Feuerstein (ugh) with a Live Chat starting now on The Street

    Feuerstein has been dead wrong more often than not (although I haven't been keeping up with his column, so his record for being right may have improved) and he has cost the small investor big gains because of his failure to even remotely entertain an opposing view to his. He reminds me quite a bit of Keith Olbermann- someone who likes to hear himself talk, but fails to recognize that there is an opposing opinion to his.

    When investing in biotech, it's best to look at both sides of the story and place your buy/sell orders accordingly. However, taking a small amount of money and, after some Due Diligence, placing it on a long shot that has a chance, as Dendreon (DNDN) did (twice), an investor has the chance at realizing substantial gains.

    Feuerstein misses that point and instead of advising investors to do their own Due Diligence, he'd rather them just read his column and take his opinion as the holy grail. That's not looking out for the little guy, and I'm sure glad that I did not heed his advice when I, as a small investor just getting started in the biotech market, would have missed the boat on quite a few stocks that have realized substantial gains after he wrote them off.

    What's comical about his latest column is that when asked about his constant sceptical opinions, he writes:

    I do love a good bear story, I must admit. Journalists are natural-born skeptics, and the high yuck factor in biotech only exacerbates the condition.

    So he's a journalist now- he says so himself.

    Someone who reports opinion over fact, is far from a journalist, especially one that is a self-proclaimed skeptic that likes a 'good bear story'. That means that he is more likely than not to take a possibly good bull story and swing it into a bear story to suit his own satisfaction- and that can cost potential investors a lot of money.

    Investors, do your own Due Diligence. That's the name of the game. Period.

    Sentiment: Buy

 
AMRN
1.030.00(0.00%)Jan 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.